Emerging therapeutic targets in tuberculosis: post-genomic era

Expert Opinion on Therapeutic Targets
Shampa KhasnobisDelphi Chatterjee

Abstract

Every minute, somewhere in the world four people die from tuberculosis (TB), yet it has been nearly 40 years since a novel drug was introduced to treat this disease. The ever increasing number of TB cases together with the advent of multi-drug resistant (MDR) TB, has stimulated the search for novel anti-TB agents. An array of novel drug targets is provided by the mycobacterial cell wall, whose integrity is essential for bacterial viability. Over the years researchers have identified potential drug targets that are associated with the synthesis of various cell wall constituents. This classic approach, together with the unravelling of the Mycobacterium tuberculosis genome sequence, has placed TB drug research in an unprecedented position. An entire new set of genetic and bioinformatic tools for probing potential drug targets is now available. As therapies using first-line drugs like isoniazid (INH) or rifampin in combination with second-line drugs, like ethambutol (EMB) still continues, a number of substituted fluoroquinolones are being considered as the new generation of anti-TB drugs for their favourable pharmacokinetic profile and excellent oral bioavailability. In this review, the future of anti-TB drugs is discussed with ref...Continue Reading

References

Dec 1, 1992·Trends in Genetics : TIG·B D Robertson, T F Meyer
Aug 1, 1988·Antimicrobial Agents and Chemotherapy·D C EusticeA M Slee
Mar 1, 1989·Reviews of Infectious Diseases·F Parenti
Mar 1, 1985·Antimicrobial Agents and Chemotherapy·H A ShoebA J Merola
Jun 1, 1970·Biochimica Et Biophysica Acta·I AzumaE Lederer
May 22, 1969·Biochemical and Biophysical Research Communications·J F PetitJ M Ghuysen
Jan 1, 1995·Annual Review of Biochemistry·P J Brennan, H Nikaido
Nov 1, 1993·Journal of General Microbiology·S PrinzisP J Brennan
Nov 1, 1995·Antimicrobial Agents and Chemotherapy·K MikusováP J Brennan
Mar 29, 1996·The Journal of Biological Chemistry·K MikusováP J Brennan
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·A E BelangerJ M Inamine
Nov 22, 1996·The Journal of Biological Chemistry·J LiuH Nikaido
Nov 22, 1996·The Journal of Biological Chemistry·M S SchermanM McNeil
Nov 22, 1996·The Journal of Biological Chemistry·K S AulakM Hatzoglou
Mar 1, 1997·Antimicrobial Agents and Chemotherapy·N LounisJ Grosset
May 1, 1997·The Journal of Pharmacy and Pharmacology·O A Higgs
Jun 6, 1997·Biochimica Et Biophysica Acta·Y XinM McNeil
Jul 1, 1997·The Journal of Antimicrobial Chemotherapy·Y I HoA F Cheng
Nov 5, 1997·Advances in Microbial Physiology·M Daffé, P Draper
Aug 1, 1997·Biochemical Society Transactions·G S Besra, P J Brennan
Jan 1, 1997·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·A WestonM R McNeil
Nov 26, 1998·Progress in Lipid Research·C E BarryY Yuan
Dec 31, 1998·Antimicrobial Agents and Chemotherapy·E MiyazakiW R Bishai
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·J Liu, H Nikaido
May 1, 1999·Antimicrobial Agents and Chemotherapy·B PhetsuksiriP J Brennan

❮ Previous
Next ❯

Citations

Jan 8, 2013·Interdisciplinary Sciences, Computational Life Sciences·Akanksha ArvindC Gopi Mohan
Jan 28, 2003·Drug Discovery Today·Noel J C Snell
Apr 15, 2004·Nature Reviews. Microbiology·Anil KoulAxel Ullrich
Jan 5, 2007·Proceedings of the American Thoracic Society·Edward S Chen, David R Moller
Nov 23, 2006·The Journal of General and Applied Microbiology·Dharmarajan SriramValakunja Nagaraja
Jan 10, 2014·Interdisciplinary Sciences, Computational Life Sciences·Akanksha ArvindC Gopi Mohan
Oct 19, 2013·Expert Review of Anti-infective Therapy·Michael A CollierKristy M Ainslie
Feb 5, 2009·Expert Opinion on Pharmacotherapy·Carole D MitnickCharles A Peloquin
Jul 19, 2011·European Journal of Medicinal Chemistry·Vijay K MarrapuKalpana Bhandari
Jun 27, 2008·Bioorganic & Medicinal Chemistry Letters·Samir GhoshSudhir Sinha
Feb 17, 2007·Bioorganic & Medicinal Chemistry Letters·David J OwenMark von Itzstein
Oct 30, 2014·Chemical Biology & Drug Design·Rangappa S KeriBhari Mallanna Nagaraja
Sep 26, 2007·Chembiochem : a European Journal of Chemical Biology·Nikolaos PapaioannouYoshito Kishi
Oct 11, 2005·Computational Biology and Chemistry·Sharmila AnishettyGautam Pennathur

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.